ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
Psychometric properties of the Chinese version of PROMIS-29 in patients receiving kidney replacement therapy.
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesThe Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) is widely used to measure health-related quality of life and common symptoms, but it has not yet been validated in patients receiving kidney replacement therapy (KRT). This study aims to evaluate the psychometric properties of the Chinese version of PROMIS-29 in patients receiving KRT.
methodsA cross-sectional survey was conducted from November 2023 to January 2024 among adult patients receiving KRT. Participants completed a clinical information questionnaire, PROMIS-29, and conventional measurement questionnaires through an online survey platform. Evaluation indicators included internal consistency, ceiling and floor effects, structural validity, convergent and discriminant validity, and criterion validity, and measurement invariance. Item characteristic curves and item information curves were also plotted.
resultsA total of 500 participants were included, with a age of (48.76±12.59) years. Cronbach's α coefficients for the 7 domains of PROMIS-29 ranged from 0.75 to 0.96. Confirmatory factor analysis demonstrated good model fit: Comparative fit index (CFI)=0.975, Tucker-Lewis index (TLI)=0.971, root mean square error of approximation (RMSEA)=0.046, and standardized root mean square residual (SRMR)=0.056. All dimensions met the assumption of unidimensionality. No differential item functioning was detected for the majority of items across subgroups, indicating good measurement invariance. Most items showed ideal item characteristic curves and acceptable item information curves.
conclusionsThe Chinese version of PROMIS-29 has good reliability, validity, and measurement invariance among Chinese patients receiving KRT and can be used to assess health-related quality of life and symptoms in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.